Advertisement
Singapore markets closed
  • Straits Times Index

    3,224.01
    -27.70 (-0.85%)
     
  • Nikkei

    40,168.07
    -594.66 (-1.46%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Bitcoin USD

    70,549.88
    +2,053.88 (+3.00%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,261.19
    +12.70 (+0.24%)
     
  • Dow

    39,832.01
    +71.93 (+0.18%)
     
  • Nasdaq

    16,406.23
    +6.71 (+0.04%)
     
  • Gold

    2,239.70
    +27.00 (+1.22%)
     
  • Crude Oil

    83.02
    +1.67 (+2.05%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • FTSE Bursa Malaysia

    1,530.60
    -7.82 (-0.51%)
     
  • Jakarta Composite Index

    7,288.81
    -21.28 (-0.29%)
     
  • PSE Index

    6,903.53
    +5.36 (+0.08%)
     

Amicus Therapeutics (FOLD) Worth Watching: Stock Rises 20.4%

Amicus Therapeutics, Inc. (FOLD) was a big mover last session, as its shares rose over 20% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the company, as the stock is now up over 36% in the past one-month timeframe.

In the last 30 days, the company witnessed three positive estimate revisions and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Amicus Therapeutics currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Other well-performing stocks in the biomedical/gene industry include Gilead Sciences Inc. (GILD), Cambrex Corporation. (CBM) and China Biologic Products, Inc. (CBPO). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




GILEAD SCIENCES INC (GILD): Free Stock Analysis Report

CAMBREX CORP (CBM): Free Stock Analysis Report

CHINA BIOLOGIC PRODUCTS INC (CBPO): Free Stock Analysis Report

AMICUS THERAPEUTICS INC (FOLD): Free Stock Analysis Report


Zacks Investment Research